Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
Retatrutide is being studied in people with obesity, overweight and type 2 diabetes, but it is not currently approved as a diabetes or weight loss treatment in the UK
The End of FDA Shortage Status for Semaglutide and Tirzepatide The FDAs removal of semaglutide and tirzepatide from its drug shortage list marked a turning point for the compounding industry
All referenced quantities are provided strictly for educational and informational context within controlled research environments
Some early research suggests that tirzepatide could reduce proteinuria and slow the progression of kidney disease in people with diabetes, though more long-term studies are needed
Peptide sequence: trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH Chemical details include: Molecular formula: CHNOS Molecular weight: ~5135.785136 Da Key modification: N-terminal trans-3-hexenoyl group CAS number: 218949-78-1 This structure preserves full GHRH bioactivity and extends the half-life in experimental systems
US$ 26.24
US$ 25.65
US$ 23.87
US$ 22.10
US$ 27.94
US$ 27.28
US$ 27.41
